These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7542762)

  • 21. Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells.
    Granot-Attas S; Elson A
    Exp Cell Res; 2004 Mar; 294(1):236-43. PubMed ID: 14980517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
    Muthuswamy SK; Siegel PM; Dankort DL; Webster MA; Muller WJ
    Mol Cell Biol; 1994 Jan; 14(1):735-43. PubMed ID: 7903421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells.
    Sistonen L; Koskinen PJ; Lehväslaiho H; Lehtola L; Bravo R; Alitalo K
    Oncogene; 1990 Jun; 5(6):815-21. PubMed ID: 1972791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation.
    Kim H; Chan R; Dankort DL; Zuo D; Najoukas M; Park M; Muller WJ
    Oncogene; 2005 Nov; 24(51):7599-607. PubMed ID: 16170374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells.
    Koskinen P; Lehväslaiho H; MacDonald-Bravo H; Alitalo K; Bravo R
    Oncogene; 1990 Apr; 5(4):615-8. PubMed ID: 1970155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src.
    Wilson LK; Parsons SJ
    Oncogene; 1990 Oct; 5(10):1471-80. PubMed ID: 1701230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase.
    Lehväslaiho H; Sistonen L; diRenzo F; Partanen J; Comoglio P; Hölttä E; Alitalo K
    J Cell Biochem; 1990 Mar; 42(3):123-33. PubMed ID: 1969420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC; Miyake T; Parsons SJ
    Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphotyrosine antibodies as probes for activated oncogene products endowed with tyrosine kinase activity.
    Prat M; Di Renzo MF; Gaudino G; Ponzetto C; Comoglio PM
    Ann Ist Super Sanita; 1991; 27(1):175-81. PubMed ID: 1720292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of autophosphorylation sites of HER2/neu.
    Hazan R; Margolis B; Dombalagian M; Ullrich A; Zilberstein A; Schlessinger J
    Cell Growth Differ; 1990 Jan; 1(1):3-7. PubMed ID: 1706616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor.
    Jin L; Craven RJ
    Oncogene; 2014 Jan; 33(3):326-35. PubMed ID: 23318459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product.
    Fendly BM; Winget M; Hudziak RM; Lipari MT; Napier MA; Ullrich A
    Cancer Res; 1990 Mar; 50(5):1550-8. PubMed ID: 1689212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
    Wada T; Myers JN; Kokai Y; Brown VI; Hamuro J; LeVea CM; Greene MI
    Oncogene; 1990 Apr; 5(4):489-95. PubMed ID: 1970151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of epidermal growth factor on the expression of erb B2/neu oncogene in mouse embryo fibroblast cells].
    Zheng YS; Tong TJ
    Shi Yan Sheng Wu Xue Bao; 1992 Dec; 25(4):413-6. PubMed ID: 1363854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nakahara memorial lecture. Non-receptor type protein-tyrosine kinases closely related to src and yes compose a multigene family.
    Toyoshima K; Semba K; Nishizawa M; Yamanashi Y; Sukegawa J; Miyajima N; Yamamoto T
    Princess Takamatsu Symp; 1986; 17():11-20. PubMed ID: 3332005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.
    Graus-Porta D; Beerli RR; Hynes NE
    Mol Cell Biol; 1995 Mar; 15(3):1182-91. PubMed ID: 7532277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.
    Olayioye MA; Beuvink I; Horsch K; Daly JM; Hynes NE
    J Biol Chem; 1999 Jun; 274(24):17209-18. PubMed ID: 10358079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells.
    Jallal B; Schlessinger J; Ullrich A
    J Biol Chem; 1992 Mar; 267(7):4357-63. PubMed ID: 1347042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of epidermal growth factor receptor expression and activation: a brief review.
    Haley JD
    Symp Soc Exp Biol; 1990; 44():21-37. PubMed ID: 2130514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.